Almedalen 2017 logos website

 

Wisby Strands Veranda & Taverna

 

After Work Almedalen

Onsdag 5 juli 2017 kl. 17:00 – 19:00

Wisby Strands Veranda

Opticom, Adxto & Mimerex
arrangerar även i år ett gemensamt mingel för våra kunder.
Vi bjuder på rosé, tilltugg samt ett lättsamt samkväm med kollegor i branschen.
Vi kommer vid tillfället att informera om våra verksamheter.

Vi hoppas att du vill komma och ser fram emot att träffa dig!

Varmt välkommen önskar
Carl Michael Bergman, Helena Östregård, Pontus Torstensson och kollegor

Tyvärr har vi ett begränsat antal platser, så anmäl dig gärna så snart som möjligt: Anmälan
Om du får förhinder, meddela oss gärna via: almedalen@opticom.se

Vill du veta mer om vad vi på Opticom, Adxto och Mimerex arbetar med? Kontakta oss gärna eller besök våra hemsidor:

Carl Michael Bergman, VD, Opticom: carl.michael@opticom.se  Opticom Group Opticom International Research

Helena Östregård, VD, Adxto helena.ostregard@adxto.com Adxto

Pontus Torstensson, VD, Mimerex pontus.torstensson@mimerex.com Mimerex

 

Download PDF
iStock_000007042359_Large

Francesco De Rosa, with vast experience from the international pharma industry at various prominent positions within sales, brand and business managing, gives the background to one of his first experiences with Opticom International Research: “At the time, I had taken over a very important Pfizer brand with a five-year legacy of declining market shares and I needed to get a 360 degree understanding of the decision-making process within the growth hormone therapy area” he explains and continues: “My scope was clear: bend the trend!”.

To gain this crucial understanding, Francesco turned to Opticom, a company which had previously delivered very good and useful results in projects for another pharmaceutical brand he had worked with. In the project of close co-operation that followed, Opticom conducted about 100 qualitative interviews with parents, paediatricians, and nurses to understand their different needs and reasoning within this therapy area.

The research discovered many “leaks” that delayed children’s access to treatment as well as large regional differences. Based on Opticom’s comprehensive analysis of the patient journey and treatment rationales, Francesco was able to change his company’s strategy, including a relocation of resources, better aligned to the customer landscape, as well as to improve communication around the value of treatment. In addition, the team could optimize its different support tools to physicians, nurses and parents, in order to facilitate earlier diagnose and better compliance.

Furthermore, Francesco and his colleagues came up with an improved treatment device to deal with an issue rated very important among respondents in the survey: Ease-of-use.

He describes the direct impact of this new, very valuable market knowledge: “Thanks to the new insights we designed a new device for the treatment of growth hormones deficiencies among children in order to meet the single most important factor in the choice of treatment: Easy-of-use of the device. This resulted in a patent available in more than 100 countries worldwide”.

As a result of the new strategy, the brand soon turned decline into growth and has been continuing this positive development ever since.

According to Francesco, the generation of updated customer insights is key to their business. Understanding both traditional and non-traditional stakeholders, their needs, as well as the patient journey and the decision-making process is fundamental in forming a successful business strategy.

In these situations you need a consulting company with a strong focus on quality, and with a thorough process for both research as well as analysis that delivers real and actionable results. That is where Opticom comes in as a very valuable partner with the staff’s vast knowledge and experience of the pharma industry:  “They are methodical in their understanding of customer needs and in making sure that the setup of the project, from the very start to result implementation, is consistent and with a great focus on details and delivery” says Francesco, who would definitely engage Opticom again to gain strategic insights and/or to facilitate optimized communication.

Download PDF

Eye for pharma pic

Opticom took the opportunity to hear and discuss What’s cooking in Pharma, at the annual Eye for Pharma’s Barcelona Conference 2017.

Buzz words such as patient empowerment, digital services, multi-stakeholder collaboration, and customer engagement confirm that the industry is clearly widening its “customer focus” to include a stronger patient centricity and closer stakeholder collaboration as well as a broader definition of offering value through innovative services.

Opticom will continue to help health companies succeed in their healthcare ecosystem. Do contact us if you would like to talk, brainstorm, and plan your next steps towards improved value propositions!

Some interesting quotes caught at Eye for Pharma Barcelona 2017:

“Technology forces us forward: pharma on its own will cause an evolution, by partnering with external partners, we will create a revolution.” (Panel discussion)

On Patient value: “We need to get patients to be proud of us – Pharma – proud of what we have achieved. We should do a better job to convince them.” (Panel discussion)

Bottom line: regardless of the value offered: “Never surprise us (patients) with any side effect!” (Ian Talmage, Senior Advisor, Bayer)

“Pharma’s role: Helping people to get better at getting better.” (Panel discussion)

“What is the most advanced pharma company when it comes to digitalization? Not just one company, but we can see indications that they are often the smaller, midsize companies, from the Nordics or Belgium.” (Dr. Frank Kumli, Executive Director, Life Sciences, EY)

Download PDF

Cars for sale. Who cares?

Think of the word “chevalier”

At first hand, it implies that a man is chivalrous. A knight, as it was called way back in the day. Someone who was quite well off. Had a good hand with the ladies. A charmer.

But if you do your linguistic (i.e. French) research right, it is far simpler than that. It means a guy who owns a horse. No more, no less. A mere horse.

Owning a horse, in the old days, extended not only your body (taller, faster, tougher) but also your persona (smarter, sexier, more powerful).

Now fast forward to present days. Few men, and women, own a horse today. But very many of us own a car. And funnily enough, we have, for the last century, attributed that ownership the same connotations as our medieval predecessors did to their horses. We love and cherish the brand of the car we own and drive.

My car makes me not only taller, faster and tougher but also smarter, sexier and more powerful. At least, that is what we think. And what makes us spend a considerable part of our income on a rather dead piece of metal and plastic. At least compared to a horse.

But now things are changing.

Cars are not sold anymore. They are leased. Or even rented by the hour (without any shady implications). Basically, cars are owned by banks. Not by individuals.

So, from being an object that you own, cars have become a service that you buy. When you need it.

Where will this – in the longer perspective – lead to in terms of brand affinity and brand asset? Will young urban drivers develop a closer relationship with those brands that provide the functionality of a car-for-hire than the brands of those manufacturers that actually make cars-for-sale.

We don’t know yet. But we can find out.

Because we create value for companies around the world by transforming data and knowledge into strategic advice and efficient communication.

Car for sale. Who cares?

Download PDF

Internet of things without a driver

Imagine one of the leaders within the automotive industry.

Paint the picture that they’ve been building vehicles for really long, been really successful and become really appreciated. Drivers just love handling these impressive machines. The mechanics are superb. The driver interface is beyond compare, and the comfort is exquisite.

Let’s say that this is a producer of professional vehicles, such as long haul trucks, wheel loaders, mining equipment or even buses. Hence, availability and cost of operation will be key to any owner. But also in this discipline, our company scores high.

One could only guess the brand assets of such a product range. And of such a corporation.

So what happens when the interactive electronics of these already advanced machines grow up and become connected? Become part of the so cherished Internet of Things.

Information technology will allow for mind boggling novelties such as vehicles that drive better on their own than with their drivers. Vehicles that thrive best with their kins, travelling whole continents in a group, or what is now called platooning. Vehicles that are performing around the clock. A traffic environment far safer, without any driver at all, however skilled they may be.

What happens then with the loyalty of the drivers? And what happens with the brand assets?

Will such a vehicle-producer be seen as a sub-supplier to Internet companies? Or is it maybe so, that an agile producer can grab this opportunity, and turn things the other way around. And build an even stronger brand?

We don’t know yet. But we can find out.

Because we help companies around the world create value by transforming data and knowledge into strategic advice and efficient communication.

Download PDF